Viral hepatitis in Saudi Arabia

References

1. ↵
   1. Abdo AA,
   2. Sanai FM,
   3. Al Faleh FZ

   (2012) Epidemiology of viral hepatitis in Saudi Arabia; Are we off the hook? Saudi J Gastroenterol 18:349–357.

   OpenUrlCrossRefPubMed
2. ↵
   1. Al Faleh F,
   2. Al Shehri S,
   3. Al Ansari S,
   4. Al Jeffri M,
   5. Al Mazrou Y,
   6. Shaffi A,
   7. et al.

   (2008) Changing patterns of hepatitis A prevalence within the Saudi population over the last 18 years. World J Gastroenterol 14:7371–7375.

   OpenUrlPubMed
3. ↵
   1. Al-Faleh FZ

   (1988) Hepatitis B infection in Saudi Arabia. Ann Saudi Med 8:474–480.

   OpenUrlWeb of Science
4. ↵
   1. Al-Faleh FZ,
   2. Al-Jeffri M,
   3. Ramia S,
   4. Al-Rashed R,
   5. Arif M,
   6. Rezeig M,
   7. et al.

   (1999) Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect 38:167–170.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Alswaidi F,
   2. O’Brien S

   (2010) Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors? J Epidemiol Community Health 64:989–997.

   OpenUrlAbstract/FREE Full Text
6. ↵
   1. Bashawri LAM,
   2. Fawaz NA,
   3. Ahmad MS,
   4. Qadi AA,
   5. Almawi WY

   (2004) Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol 26:225–228.

   OpenUrlCrossRefPubMed
7. 1. Mehdi SR,
   2. Pophali A,
   3. Al-Abdul Rahim KA

   (2000) Prevalence of hepatitis B and C and blood donors. Saudi Med J 21:942–944.

   OpenUrlPubMed
8. ↵
   1. El-Hazmi MM

   (2004) Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J 25:26–33.

   OpenUrlPubMedWeb of Science
9. ↵
   1. Madani TA

   (2007) Hepatitis C virus infections reported in Saudi Arabia over 11 years of surveillance. Ann Saudi Med 27:191–194.

   OpenUrlPubMed
10. ↵
    1. Sievert W,
    2. Altraif I,
    3. Razavi HA,
    4. Abdo A,
    5. Ahmed EA,
    6. Alomair A,
    7. et al.

    (2011) A systematic review of hepatitis C virus epidemiology in Asia, Australia, and Egypt. Liver Int, 61–80.
11. ↵
    1. Alghamdi AS,
    2. Alqutub A,
    3. Abaalkhail F,
    4. Sanai FM,
    5. Alghamdi H,
    6. Altraif I,
    7. et al.

    (2015) SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection. Saudi J Gastroenterol 21:60–63.

    OpenUrl